Cheryl Gault's Insider Trades & SAST Disclosures

Cheryl Gault's most recent trade in Rapport Therapeutics Inc. was a trade of 13,987 Common Stock done . Disclosure was reported to the exchange on March 3, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Rapport Therapeutics Inc.
Cheryl Gault Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 13,987 171,928 - 0 Common Stock
Rapport Therapeutics Inc.
Cheryl Gault Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 129,000 129,000 - - Stock Option (Right to Buy)
Rapport Therapeutics Inc.
Cheryl Gault Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 88,442 88,442 - - Stock Option (Right to Buy)
Cyclerion Therapeutics Inc
Cheryl Gault Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2022 135,000 135,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades